Skip to content

Analysis of the efficacy of quadruple therapy and dual therapy in the real world for Helicobacter pylori

Analysis of the efficacy of quadruple therapy and dual therapy in the real world for Helicobacter pylori

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118211
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-02-05
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

helicobacter pylori infection

Interventions

control quadruple group and Observation of the dual therapy group:NA

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with Helicobacter pylori infection during the case collection period who had received quadruple or dual therapy in the treatment regimen.

Exclusion criteria

Exclusion criteria: 1.Incomplete clinical information; 2.The study participants had previously explicitly stated that their medical records could not be used for the research.

Design outcomes

Primary

MeasureTime frame
HP eradication rate;

Secondary

MeasureTime frame
inflammation level;Occurrence of adverse reactions;clinical efficacy;

Countries

China

Contacts

Public ContactFengqin Jiang

Huzhou Center Hospital

hzszxyyll@163.com+86 572 2709719

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026